ADC Therapeutics SA (ADCT) Discusses ZYNLONTA Data at ASH and Strategic Financial Restructuring - Slideshow

🇨🇭 Seeking Alpha (CH) —

AI Summary

ADC Therapeutics discussed ZYNLONTA data presented at the American Society of Hematology meeting and a strategic financial restructuring. The headline signals both clinical-development news and a company-finance update, without specifying the data or restructuring terms.

Markets Deals Health ADC Therapeutics ZYNLONTA ASH clinical data financial restructuring biotechnology

Read original source →